Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

Bullboard Posts

Comment by demarkoon Apr 14, 2008 2:35pm

330 Views

Post# 14969066

RE: Starting over ??

I think we are all scratching our heads and and wondering what is happening to the SP and support for HALO.

The boards are dried up, and no one has answers.

Like said, great properties, results are good, management is SOLID.

People are getting impatient?

Whats your take on it?

D

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism